SYSinflame and e:AtheroSysMed kicked-off

Two projects applying system medicine approaches to unravel the pathogenesis of atherosclerosis and inflammatory diseases started in 2014 with funding by the BMBF.
The IIEG is co-leading e:AtheroSysMed together with Prof. Schunkert (DHM) and is partner in SYSinflame aiming to understand the shared genetic basis of psoriasis and atherosclerosis.


Scroll to Top